By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aurinia (Formerly Known as Isotechnika Pharma Inc.) 

5120 - 75th Street

Edmonton  Alberta  T6E 6W2  Canada
Phone: 780-487-1600 Fax: 780-484-4105


SEARCH JOBS


Key Statistics


Email:
Ownership: Public

Web Site: Aurinia
Employees:
Symbol: AUPH
 









Company News
Aurinia (AUPH) Releases Additional 48-Week Data From The AURA-LV Study During Late-Breaking Session At National Kidney Foundation 2017 Spring Clinical Meetings 4/21/2017 6:15:35 AM
Aurinia (AUPH) Completes Licensing Deal With Merck Animal Health For Its Nanomicellar Formulation Of Voclosporin For The Treatment Of Canine Dry Eye Syndrome 4/18/2017 7:11:59 AM
Aurinia (AUPH) To Host Investor Event And Webcast On April 20th In Orlando, FL 4/11/2017 6:46:32 AM
Aurinia (AUPH) Announces Development Plans For Voclosporin In Europe And Japan 4/7/2017 7:50:50 AM
Aurinia (AUPH) Highlights 48-Week Data From Open-Label AURION Study At 12th International Congress On SLE (LUPUS 2017) & The 7th Asian Congress On Autoimmunity (ACA 2017) 3/27/2017 6:33:28 AM
Aurinia (AUPH) Closes US$173.1 Million Public Offering Of Common Shares And Full Exercise Of Underwriters' Option To Purchase Additional Common Shares 3/21/2017 6:57:54 AM
Aurinia (AUPH) Announces Presentation At 12th International Congress On SLE (LUPUS 2017) & The 7th Asian Congress On Autoimmunity (ACA 2017) 3/17/2017 6:36:11 AM
Aurinia (AUPH) Announces Public Offering Of Common Shares 3/14/2017 6:51:43 AM
Aurinia (AUPH) Prices US$150.5 Million Public Offering Of Common Shares 3/14/2017 6:24:43 AM
Aurinia (AUPH) Reports Fourth Quarter And Full Year 2016 Financial Results And Recent Operational Highlights 3/9/2017 8:22:30 AM
12345678910...
//-->